Nautilus Biotechnology shares surge 19.47% intraday after announcing participation in Investor Summit Group Virtual Conference.

Nautilus Biotechnology (NASDAQ: NAUT) surged 19.47% intraday after announcing its participation in the Investor Summit Group Virtual Conference, with management scheduled to present on March 25, 2026. The event, highlighting the company’s proteomics platform and mission to democratize access to the proteome, likely boosted investor confidence in its long-term growth prospects. Other news, including a hotel renovation and a music label launch, were unrelated to the biotech firm. The stock’s sharp rise aligns with the positive market reaction to increased visibility and strategic communication efforts by the company.